Danaher Corporation (NYSE:DHR) declared a quarterly dividend on Tuesday, December 5th, RTT News reports. Stockholders of record on Friday, December 29th will be paid a dividend of 0.14 per share by the conglomerate on Friday, January 26th. This represents a $0.56 dividend on an annualized basis and a dividend yield of 0.60%.

Danaher has increased its dividend by an average of 97.8% per year over the last three years and has increased its dividend every year for the last 3 years. Danaher has a payout ratio of 14.0% meaning its dividend is sufficiently covered by earnings. Research analysts expect Danaher to earn $4.32 per share next year, which means the company should continue to be able to cover its $0.56 annual dividend with an expected future payout ratio of 13.0%.

Shares of Danaher (DHR) traded down $0.08 on Tuesday, hitting $92.74. The stock had a trading volume of 2,376,939 shares, compared to its average volume of 2,632,848. Danaher has a fifty-two week low of $76.27 and a fifty-two week high of $94.82. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.00 and a current ratio of 1.43. The firm has a market cap of $65,261.68, a PE ratio of 24.12, a PEG ratio of 2.23 and a beta of 1.02.

Danaher (NYSE:DHR) last issued its earnings results on Thursday, October 19th. The conglomerate reported $1.00 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.95 by $0.05. Danaher had a return on equity of 11.29% and a net margin of 13.36%. The business had revenue of $4.53 billion during the quarter, compared to analysts’ expectations of $4.47 billion. During the same period in the prior year, the firm posted $0.87 EPS. Danaher’s quarterly revenue was up 9.6% compared to the same quarter last year. analysts anticipate that Danaher will post 3.99 earnings per share for the current fiscal year.

A number of equities research analysts recently commented on DHR shares. J P Morgan Chase & Co restated an “overweight” rating and set a $95.00 price target on shares of Danaher in a research report on Friday, September 8th. Zacks Investment Research upgraded Danaher from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research report on Thursday, October 5th. Morgan Stanley restated an “overweight” rating and set a $95.00 price target (up from $86.00) on shares of Danaher in a research report on Friday, October 6th. Cowen restated a “buy” rating and set a $90.00 price target on shares of Danaher in a research report on Wednesday, October 4th. Finally, Credit Suisse Group increased their price target on Danaher from $93.00 to $96.00 and gave the stock an “outperform” rating in a research report on Friday, October 20th. One analyst has rated the stock with a sell rating, four have assigned a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company. Danaher has a consensus rating of “Buy” and an average target price of $93.31.

In other news, CAO Robert S. Lutz sold 11,189 shares of the firm’s stock in a transaction on Monday, October 23rd. The stock was sold at an average price of $91.66, for a total value of $1,025,583.74. Following the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at approximately $1,678,661.24. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, SVP Daniel Raskas sold 37,870 shares of the firm’s stock in a transaction on Thursday, November 16th. The stock was sold at an average price of $93.33, for a total value of $3,534,407.10. The disclosure for this sale can be found here. Insiders sold a total of 273,810 shares of company stock worth $25,218,813 over the last quarter. Corporate insiders own 12.20% of the company’s stock.

COPYRIGHT VIOLATION NOTICE: This story was originally published by American Banking News and is owned by of American Banking News. If you are reading this story on another domain, it was illegally copied and reposted in violation of US & international copyright law. The legal version of this story can be read at https://www.americanbankingnews.com/2017/12/05/danaher-corporation-dhr-plans-0-14-quarterly-dividend.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Dividend History for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.